Mumps virus strain B level jeryl lynn live antigen
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Name
- Mumps virus strain B level jeryl lynn live antigen
- Accession Number
- DB10316
- Description
Mumps virus strain B level jeryl lynn live antigen is a live attenuated virus vaccine for subcutenous injection. It is an active immunization against mumps, which is a common childhood disease.
- Type
- Biotech
- Groups
- Approved, Investigational
- Biologic Classification
- Vaccines
Attenuated - Synonyms
- Mumps Virus Vaccine Live, Jeryl Lynn Strain
Pharmacology
Accelerate your drug discovery research with the industry’s only fully connected ADMET dataset, ideal for:Accelerate your drug discovery research with our fully connected ADMET dataset- Indication
- Not Available
- Associated Conditions
- Contraindications & Blackbox Warnings
Contraindications & Blackbox WarningsWith our commercial data, access important information on dangerous risks, contraindications, and adverse effects.Our Blackbox Warnings cover Risks, Contraindications, and Adverse Effects- Pharmacodynamics
- Not Available
- Mechanism of action
- Not Available
- Absorption
- Not Available
- Volume of distribution
- Not Available
- Protein binding
- Not Available
- Metabolism
- Not Available
- Route of elimination
- Not Available
- Half-life
- Not Available
- Clearance
- Not Available
- Adverse Effects
Reduce medical errorsand improve treatment outcomes with our comprehensive & structured data on drug adverse effects.Reduce medical errors & improve treatment outcomes with our adverse effects data- Toxicity
- Not Available
- Affected organisms
- Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Comprehensive & structured drug product infoFrom application numbers to product codes, connect different identifiers through our commercial datasets.Easily connect various identifiers back to our datasets- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image M-M-R II Mumps virus strain B level jeryl lynn live antigen (12500 [TCID_50]/0.5mL) + Measles virus vaccine live attenuated (1000 [TCID_50]/0.5mL) + Rubella virus vaccine (1000 [TCID_50]/0.5mL) Injection, powder, lyophilized, for suspension Subcutaneous A-S Medication Solutions 1971-04-21 Not applicable US 
M-M-R II Mumps virus strain B level jeryl lynn live antigen (12500 [TCID_50]/0.5mL) + Measles virus vaccine live attenuated (1000 [TCID_50]/0.5mL) + Rubella virus vaccine (1000 [TCID_50]/0.5mL) Injection, powder, lyophilized, for suspension Subcutaneous Physicians Total Care, Inc. 1996-08-07 2012-06-30 US M-M-R II Mumps virus strain B level jeryl lynn live antigen (12500 TCID50/0.5mL) + Measles virus vaccine live attenuated (1000 TCID50/0.5mL) + Rubella virus vaccine (1000 TCID50/0.5mL) Powder, for solution Subcutaneous Merck Ltd. 1979-12-31 Not applicable Canada 
M-M-R II Mumps virus strain B level jeryl lynn live antigen (12500 [TCID_50]/0.5mL) + Measles virus vaccine live attenuated (1000 [TCID_50]/0.5mL) + Rubella virus vaccine (1000 [TCID_50]/0.5mL) Injection, powder, lyophilized, for suspension Subcutaneous Merck Sharp & Dohme Corp. 1971-04-21 Not applicable US M-M-rvaxpro Mumps virus strain B level jeryl lynn live antigen (12500 TCID50) + Measles virus vaccine live attenuated (1000 TCID50) + Rubella virus vaccine (1000 TCID50) Msd Vaccins 2021-02-10 Not applicable EU 
M-M-rvaxpro Mumps virus strain B level jeryl lynn live antigen (12500 TCID50) + Measles virus vaccine live attenuated (1000 TCID50) + Rubella virus vaccine (1000 TCID50) Msd Vaccins 2021-02-10 Not applicable EU M-M-rvaxpro Mumps virus strain B level jeryl lynn live antigen (12500 TCID50) + Measles virus vaccine live attenuated (1000 TCID50) + Rubella virus vaccine (1000 TCID50) Msd Vaccins 2021-02-10 Not applicable EU M-M-rvaxpro Mumps virus strain B level jeryl lynn live antigen (12500 TCID50) + Measles virus vaccine live attenuated (1000 TCID50) + Rubella virus vaccine (1000 TCID50) Msd Vaccins 2021-02-10 Not applicable EU M-M-rvaxpro Mumps virus strain B level jeryl lynn live antigen (12500 TCID50) + Measles virus vaccine live attenuated (1000 TCID50) + Rubella virus vaccine (1000 TCID50) Msd Vaccins 2021-02-10 Not applicable EU M-M-rvaxpro Mumps virus strain B level jeryl lynn live antigen (12500 TCID50) + Measles virus vaccine live attenuated (1000 TCID50) + Rubella virus vaccine (1000 TCID50) Msd Vaccins 2021-02-10 Not applicable EU
Categories
- Drug Categories
- Classification
- Not classified
Chemical Identifiers
- UNII
- 47QB6MX9KU
- CAS number
- Not Available
References
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Completed Not Available Rheumatoid Arthritis, Juvenile 1 4 Completed Prevention Adverse Event Following Immunization / Mumps / Rubella / Rubeola 1 4 Completed Prevention BCG Infection / Immune Response / Reaction - Vaccine 1 4 Completed Prevention Chickenpox / Hepatitis A / Mumps / Rubella / Rubeola 1 4 Completed Prevention Encephalitis, Japanese B / Mumps / Rubella / Rubeola 1 4 Completed Prevention Hepatitis A Virus 1 4 Completed Prevention Hepatitis A / Mumps / Rubella / Rubeola 1 4 Completed Prevention Mumps / Rubella / Rubeola 2 4 Completed Treatment Human Immunodeficiency Virus (HIV) Infections 1 4 Completed Treatment Mumps / Rubella / Rubeola / Varicella 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection, powder, lyophilized, for solution Subcutaneous Injection, powder, lyophilized, for suspension Subcutaneous Injection, powder, for suspension Intramuscular; Subcutaneous Injection, powder, lyophilized, for solution Intramuscular; Subcutaneous Injection, powder, for solution Subcutaneous Kit; powder, for solution Intramuscular; Subcutaneous Injection, solution Intramuscular; Subcutaneous Injection, powder, for solution Intramuscular; Subcutaneous Injection Injection, powder, lyophilized, for suspension Intramuscular; Subcutaneous Powder, for solution Subcutaneous Solution Injection Subcutaneous Injection, powder, lyophilized, for suspension Powder - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created on December 01, 2015 20:03 / Updated on June 12, 2020 16:53